Jefferies Financial Group Raises Compass Therapeutics (NASDAQ:CMPX) Price Target to $8.00
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) had its price target increased by research analysts at Jefferies Financial Group from $7.00 to $8.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside […]
Compass Therapeutics (NASDAQ:CMPX – Get Free Report) had its price target increased by research analysts at Jefferies Financial Group from $7.00 to $8.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm currently has a “buy” rating on the stock. Jefferies Financial Group’s target price would indicate a potential upside […]
